×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Section 99: Purinergic Signaling and P2X/P2Y Receptors in CB
therapeutic
2,921 words
KG: ent-dise-bfd8f32d
2026-03-24
section:therapeutics
kind:therapeutic
topic:cbs
topic:psp
topic:purinergic-signaling
topic:p2x7
topic:neuroinflammation
Contents
Section 99: Purinergic Signaling and P2X/P2Y Receptors in CBS/PSP
💊
Therapeutic Info
Name
Section 99: Purinergic Signaling and P2X/P2Y Receptors in CBS/PSP
Summary
ATP signaling, P2X ionotropic receptors (P2X7), P2Y GPCRs, neuroinflammation modulation, P2X7 antagonists, and therapeutic approaches for CBS/PSP patients
Knowledge Graph
Related Hypotheses (30)
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Smartphone-Detected Motor Variability Correction
Score: 0.56
Adenosine-Astrocyte Metabolic Reset
Score: 0.56
Purinergic Signaling Polarization Control
Score: 0.55
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55
Retinal Vascular Microcirculation Rescue
Score: 0.54
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.53
Senescence-Associated Myelin Lipid Remodeling
Score: 0.51
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat
Score: 0.50
Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.50
Ganglioside Rebalancing Therapy
Score: 0.50
Orexin-Microglia Modulation Therapy
Score: 0.49
Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.49
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.48
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48
Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.48
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.48
Ocular Immune Privilege Extension
Score: 0.47
Sphingomyelin Synthase Activators for Raft Remodeling
Score: 0.47
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45
Hypocretin-Neurogenesis Coupling Therapy
Score: 0.45
Reelin-Mediated Cytoskeletal Stabilization Protocol
Score: 0.45
Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution
Score: 0.45
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44
Glial Glycocalyx Remodeling Therapy
Score: 0.41
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
Show 25 more
Related Analyses (13)
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Show 8 more
Related Experiments (19)
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.46
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.46
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.46
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.46
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.46
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.46
Cytochrome Therapeutics
clinical · proposed · Score: 0.46
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.46
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.46
Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.46
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.46
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.46
tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.46
Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.46
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.46
P2rx7 congenic mouse model glucose tolerance testing
validation · proposed · Score: 0.90
P2RX7 variant rs1718119 association with glucose homeostasis
exploratory · proposed · Score: 0.90
Show 14 more
See Also (15)
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 33 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 33 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 33 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 33 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 33 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 33 hypotheses
ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 33 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 34 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 34 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 34 hypotheses
Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 33 hypotheses
Tau Kinase Signaling Cascade in Alzheimer's Disease
mechanism · Pages share 32 hypotheses
T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 33 hypotheses
Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 33 hypotheses
synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 33 hypotheses
Show 10 more